Detect Covid-19 Test Product/Model Number: 21205 — FDA record Z-0879-2023

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 8, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Detect Covid-19 Test Product/Model Number: 21205
Reason
There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of supportive treatment and lack of monitoring of infected individuals and their household or other close contacts for symptoms resulting in increased risk of spread of COVID-19 within the community.
Classification
Class II
Recalling firm
Detect Headquarters
Quantity
10142 (US); 960 OUS
Agency-reported status
Ongoing
Source record identifier
Z-0879-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityHY263, HY264, and HB264 Expiration 01JAN2023

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Domestic distribution nationwide. Foreign distribution to Hong Kong.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jan 11, 2023
Recall initiation date
Dec 8, 2022
Center classification date
Jan 4, 2023

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records